Clinical Trial Update: Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adebrelimab as maintenance therapy after concurrent chemoradiotherapy with hyperfractionated radiotherapy in limited-stage small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Small Cell Lung Cancer, Limited Stage, Hyperfractionated Accelerated Radiotherapy | Phase 2 | Status: NOT_YET_RECRUITING